Acurx Pharmaceuticals, Inc. (ACXP)
NASDAQ: ACXP · Real-Time Price · USD
4.860
+0.140 (2.97%)
At close: Aug 14, 2025, 4:00 PM
4.880
+0.020 (0.41%)
After-hours: Aug 14, 2025, 4:15 PM EDT
Acurx Pharmaceuticals Market Cap
Acurx Pharmaceuticals has a market cap or net worth of $7.32 million as of August 14, 2025. Its market cap has decreased by -79.37% in one year.
Market Cap
7.32M
Enterprise Value
1.20M
1-Year Change
-79.37%
Ranking
Category
Stock Price
$4.86
Market Cap Chart
Since the IPO on June 25, 2021, Acurx Pharmaceuticals's market cap has decreased from $57.25M to $7.32M, a decrease of -87.21%. That is a compound annual growth rate of -39.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 7.26M | -47.20% |
| Dec 31, 2024 | 13.75M | -73.92% |
| Dec 29, 2023 | 52.73M | 14.29% |
| Dec 30, 2022 | 46.14M | 4.51% |
| Dec 31, 2021 | 44.15M | -22.88% |
| Jun 25, 2021 | 57.25M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 592.95B |
| Johnson & Johnson | 420.06B |
| AbbVie | 355.91B |
| UnitedHealth Group | 246.17B |
| AstraZeneca | 240.81B |
| Novartis AG | 234.72B |
| Novo Nordisk | 227.37B |
| Abbott Laboratories | 225.22B |